AthenaKritharisMD

Oncology • New Brunswick, NJ

Hematologic Oncology

Assistant Professor of Medicine

Join to view full profile

Dr. Kritharis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kritharis' full profile

Already have an account?

Office
195 Little Albany St
New Brunswick, NJ 08901
Phone+1 732-235-4439

Fax+1 732-448-7887

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2009 - 2012
New York University School of MedicineClass of 2009, MD
New York UniversityBA, Chemistry, Mathematics, Magna Cum Laude, Honors in Chemistry

Certifications & Licensure

NY State Medical License 2010 - Present
NJ State Medical License 2018 - 2025
MA State Medical License 2013 - 2018
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

ECOG Young Investigator
American Society of Hematology Abstract Achievement Award
Julia Zelmanovich Alumni Award NYU School of Medicine
Chief Resident Hofstra Northwell School of Medicine
Chief Fellow Tufts Medical Center
Phi Lambda Upsilon Honorary Chemistry Society
Presidential Honors Scholar New York University
Award for Leadership and Volunteerism New York University
Medicine Essay Clerkship Award NYU School of Medicine
Join now to see all

Clinical Trials

Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15
Recruiting
Phase 3
Roles: Contact

Publications & Presentations

PubMed

1 citations
An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors.
Dashnamoorthy Ravi, Afshin Beheshti, Kristine Burgess, Athena Kritharis, Ying Chen
Biomedicines. 2022-10-27
30 citations
Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
Dashnamoorthy Ravi, Afshin Beheshti, Nassera Abermil, Frank C. Passero, Jaya Sharma
Cancer Research. 2016-06-01
112 citations
Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective
Athena Kritharis, Hanny Al-Samkari, David J. Kuter
Haematologica. 2018-09-01

Lectures

Deep DNA Sequencing Identifies Small Mutations in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Analysis of Intratumor ...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Small Mutations Identified Through Deep DNA Sequencing for AML and MDSDecember 9th, 2019